Literature DB >> 8512312

Cultured Ehrlich ascites tumor cells show increased N-linked alpha 2,6-sialyltransferase activity.

M K Mostafapour1, I J Goldstein.   

Abstract

Ehrlich ascites tumor cells (EAT cells) are routinely grown in the peritoneal cavity of mice. These cells, EAT-wt, grow in suspension and exhibit a high level of alpha-2,3-O-linked sialyltransferase activity with benzyl-T-antigen (Gal beta 1,3Ga1NAc-alpha-O-CH2C6H5) as acceptor. These cells also contain a very low level of alpha-2,6-O-linked and alpha-2,6-N-linked sialyltransferase activity. A variant of these cells, EAT-c, has been selected to grow in cell culture, attached to the surface of culture flasks. EAT-c cells exhibit a selective increase of two- to fivefold in the activity of alpha-2,6-N-linked sialyltransferase activity, using asialo-alpha 1-acid glycoprotein as acceptor. Since a similar selective increase has been previously observed in metastatic human colorectal cancer tissues, the EAT-wt/EAT-c cell system may serve as a good experimental model for the investigation of sialyltransferases and their cell surface sialylated products in relation to cancer, metastasis, and cell-cell interaction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8512312     DOI: 10.1006/abbi.1993.1280

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  3 in total

1.  Determinants of differential liver-colonizing potential of variants of the MCA-38 murine colon cancer cell line.

Authors:  J J Piscatelli; S A Cohen; C S Berenson; P Lance
Journal:  Clin Exp Metastasis       Date:  1995-03       Impact factor: 5.150

2.  Characterization of gangliosides from Ehrlich ascites tumour cells and their variants.

Authors:  E Kishida; I J Goldstein
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916

3.  Synthesis and expression of CDw75 antigen in human colorectal cancer.

Authors:  Clotilde Costa-Nogueira; Susana Villar-Portela; Elisa Cuevas; Emilio Gil-Martín; Almudena Fernández-Briera
Journal:  BMC Cancer       Date:  2009-12-10       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.